Skip to main content

Table 2 Relation and distribution of studied risk factors to HPV DNA status

From: Prevalence of human papilloma virus (HPV) and its genotypes in cervical specimens of Egyptian women by linear array HPV genotyping test

  DNA results (n = 152) p value
Negative (n = 90) Positive (n = 62)
Age (years) Mean ± S.D. 29.53 ± 4.61 29.93 ± 5.27 0.619
Age group (n, %)    
21-25 years 19 (21.1 %) 14 (22.6 %)  
26-30 years 35 (38.9 %) 19 (30.6 %) 0.741
31-35 years 25 (27.8 %) 19 (30.6 %)  
35-40 years 11 (12.2 %) 10 (16.1 %)  
Parity    
Nullipara 15 (16.7 %) 10 (16.1 %) 0.930
Multipara 75 (83.3 %) 52 (83.9 %)  
Residence    
Urban 62 (68.9 %) 42 (67.7 %) 0.881
Rural 28 (31.1 %) 20 (32.3 %)  
Occupation    
Housewife 70 (77.8 %) 46 (74.2 %) 0.609
Worker 20 (22.2 %) 16 (25.8 %)  
Smoking    
No 81 (90.0 %) 55 (88.7 %) 0.799
Yes 9 (10.0 %) 7 (11.3 %)  
Contraception    
No 39 (43.3 %) 23 (37.1 %) 0.442
Yes 51 (56.7 %) 39 (62.9 %)  
Gynecological findings    
Normal (n = 97) 65 32  
Multiple genital warts (n = 12) 0.0 (0 %) 12 (19.4 %) 0.000
 Intermenstrual bleeding (13) 8.0 (8.9 %) 5.0 (8.1 %) 0.858
 Post-coital bleeding (30) 17 (18.9 %) 13 (21.0 %) 0.752
Distribution of HPV DNA status according to cervical cytology and biopsy results
Normal (n = 101) 90 (100) 11 (17.7) 0.000a
LSIL (n = 35) 0.0 35 (56.5)
HSIL (n = 2) 0.0 2.0 (3.2)
Invasive SCC (n = 14) 0.0 14 (22.6)
  1. a MC Monte Carlo Sig. (2-sided)